Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.0306170 on August 30, 2006

Published online before print August 30, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0306170v1
81/1/28    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Foell, D.
Right arrow Articles by Roth, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foell, D.
Right arrow Articles by Roth, J.
(Journal of Leukocyte Biology. 2007;81:28-37.)
© 2007 by Society for Leukocyte Biology

S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules

Dirk Foell*,{dagger}, Helmut Wittkowski*,{dagger}, Thomas Vogl{dagger} and Johannes Roth*,{dagger},1

* Department of Pediatrics and
{dagger} Institute of Experimental Dermatology, University of Muenster, Muenster, Germany

1Correspondence: Department of Pediatrics, University of Muenster Albert-Schweitzer-Str. 33, Muenster D-48149, Germany. E-mail: rothj{at}uni-muenster.de

ABSTRACT

Damage-associated molecular pattern (DAMP) molecules have been introduced as important proinflammatory factors of innate immunity. One example known for many years to be expressed in cells of myeloid origin are phagocytic S100 proteins, which mediate inflammatory responses and recruit inflammatory cells to sites of tissue damage. An emerging concept of pattern recognition involves the multiligand receptor for advanced glycation end products (RAGE) and Toll-like receptors (TLRs) in sensing not only pathogen-associated molecular patterns (PAMPs) but also endogenous DAMPs, including S100 proteins. S100A8, S100A9, and S100A12 are found at high concentrations in inflamed tissue, where neutrophils and monocytes belong to the most abundant cell types. They exhibit proinflammatory effects in vitro at concentrations found at sites of inflammation in vivo. Although S100A12 binds to RAGE, at least part of the proinflammatory effects of the S100A8/S100A9 complex depend upon interaction with other receptors. Because of the divergent expression patterns, the absence of S100A12 in rodents, the different interaction partners described, and the specific intracellular and extracellular effects reported for these proteins, it is important to differentiate between distinct S100 proteins rather than subsuming them with the term "S100/calgranulins." Analyzing the molecular basis of the specific effects exhibited by these proteins in greater detail bears the potential to elucidate important mechanisms of innate immunity, to establish valid biomarkers of phagocytic inflammation, and eventually to reveal novel targets for innovative anti-inflammatory therapies.

Key Words: myeloid related protein 8 (MRP8) • MRP14 • calgranulin • calprotectin • extracellular newly identified RAGE binding protein (EN-RAGE)




This article has been cited by other articles:


Home page
J. Immunol.Home page
P. Pouliot, I. Plante, M.-A. Raquil, P. A. Tessier, and M. Olivier
Myeloid-Related Proteins Rapidly Modulate Macrophage Nitric Oxide Production during Innate Immune Response
J. Immunol., September 1, 2008; 181(5): 3595 - 3601.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Wolf, O. M. Z. Howard, H.-F. Dong, C. Voscopoulos, K. Boeshans, J. Winston, R. Divi, M. Gunsior, P. Goldsmith, B. Ahvazi, et al.
Chemotactic Activity of S100A7 (Psoriasin) Is Mediated by the Receptor for Advanced Glycation End Products and Potentiates Inflammation with Highly Homologous but Functionally Distinct S100A15
J. Immunol., July 15, 2008; 181(2): 1499 - 1506.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. A. Mares, S. S. Ojeda, E. G. Morris, Q. Li, and J. M. Teale
Initial Delay in the Immune Response to Francisella tularensis Is Followed by Hypercytokinemia Characteristic of Severe Sepsis and Correlating with Upregulation and Release of Damage-Associated Molecular Patterns
Infect. Immun., July 1, 2008; 76(7): 3001 - 3010.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. de Seny, M. Fillet, C. Ribbens, R. Maree, M.-A. Meuwis, L. Lutteri, J.-P. Chapelle, L. Wehenkel, E. Louis, M.-P. Merville, et al.
Monomeric Calgranulins Measured by SELDI-TOF Mass Spectrometry and Calprotectin Measured by ELISA as Biomarkers in Arthritis
Clin. Chem., June 1, 2008; 54(6): 1066 - 1075.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. X. Yan, C. Armishaw, J. Goyette, Z. Yang, H. Cai, P. Alewood, and C. L. Geczy
Mast Cell and Monocyte Recruitment by S100A12 and Its Hinge Domain
J. Biol. Chem., May 9, 2008; 283(19): 13035 - 13043.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. Martinon
Detection of immune danger signals by NALP3
J. Leukoc. Biol., March 1, 2008; 83(3): 507 - 511.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. Frosch and J. Roth
New insights in systemic juvenile idiopathic arthritis--from pathophysiology to treatment
Rheumatology, February 1, 2008; 47(2): 121 - 125.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. D. Behrens, W. M. Wagner, C. J. Krco, C. L. Erskine, K. R. Kalli, J. Krempski, E. A. Gad, M. L. Disis, and K. L. Knutson
The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity
Blood, February 1, 2008; 111(3): 1472 - 1479.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
T Kaiser, J Langhorst, H Wittkowski, K Becker, A W Friedrich, A Rueffer, G J Dobos, J Roth, and D Foell
Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome
Gut, December 1, 2007; 56(12): 1706 - 1713.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. E. Bianchi
DAMPs, PAMPs and alarmins: all we need to know about danger
J. Leukoc. Biol., January 1, 2007; 81(1): 1 - 5.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society for Leukocyte Biology.